Rinati Skin Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Rinati Skin's estimated annual revenue is currently $2M per year.(i)
  • Rinati Skin's estimated revenue per employee is $155,000

Employee Data

  • Rinati Skin has 13 Employees.(i)
  • Rinati Skin grew their employee count by 0% last year.

Rinati Skin's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Rinati Skin?

Rinati Skin, LLC is a cutting-edge research, design, and manufacturing company specializing in the field of cosmetic and bio-pharmacological application of stem-cells and their secretory factors. Our Founder and CEO, Dr. Nathan Newman, has dedicated his career to researching and delivering the benefits of stem cells for his patients. Since 2009, his technology has been used to deliver cosmetic products to consumers around the world. Under his leadership, our team of scientists continues to focus on developing transformative biopharmaceutical products using commercial applications of stem cell technology. Thinking out of the box is a pillar of our corporate culture. Our multidisciplinary team works collaboratively in our state-of-the-art GMP, FDA registered facilities to research, develop, and manufacture multiple lines of products using our proprietary technology. Our product lines include wellness and beauty, OTC, Veterinary, and biopharma and include specific solutions for skin and hair care, pain management, dog supplements, alcohol free hand sanitizer, and many more.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M138%N/A
#2
$1.7M138%N/A
#3
N/A14-67%N/A
#4
N/A1440%N/A
#5
$1.2M1427%N/A